Trial Details
COMPLETEDBasic Information
| Clinical ID | c1707 |
|---|---|
| Identifier | NCT02148640 |
| Trial Title | The NOR-SWITCH Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Rheumatoid Arthritis|Spondyloarthritis|Psoriatic Arthritis|Ulcerative Colitis|Crohn's Disease|Psoriasis Chronic |
| Interventions | DRUG: Innovator infliximab|DRUG: Biosimilar infliximab |
Participant Information
| Sponsor | Diakonhjemmet Hospital |
|---|---|
| City | Arendal |
| Country/Region | Norway |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-10-14 |
|---|---|
| Primary Completion Date | 2025-06-16 |
| Completion Date | 2025-01-17 |